Published in Immunity on March 01, 1996
Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A (2001) 2.54
C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat Immunol (2000) 2.49
Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17
Germinal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells. J Exp Med (2000) 2.03
Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci U S A (2000) 2.03
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med (1998) 1.78
Complement activation is required for induction of a protective antibody response against West Nile virus infection. J Virol (2005) 1.75
Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J (1997) 1.73
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med (1997) 1.59
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med (2000) 1.51
Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci U S A (1997) 1.42
Humoral response to herpes simplex virus is complement-dependent. Proc Natl Acad Sci U S A (1999) 1.35
B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med (2002) 1.32
Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am J Pathol (2002) 1.29
CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med (1997) 1.26
OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J (1998) 1.25
Follicular dendritic cells specifically express the long CR2/CD21 isoform. J Exp Med (1997) 1.25
The cytoskeleton coordinates the early events of B-cell activation. Cold Spring Harb Perspect Biol (2011) 1.17
Lymph node germinal centers form in the absence of follicular dendritic cell networks. J Exp Med (1999) 1.16
Essential role of EBF1 in the generation and function of distinct mature B cell types. J Exp Med (2012) 1.12
Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med (1998) 1.08
B-1 cell development: evidence for an uncommitted immunoglobulin (Ig)M+ B cell precursor in B-1 cell differentiation. J Exp Med (1998) 1.06
T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J Exp Med (1998) 1.05
Enhanced humoral immune responses against T-independent antigens in Fc alpha/muR-deficient mice. Proc Natl Acad Sci U S A (2009) 1.05
Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1. J Exp Med (2005) 1.04
Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol (2005) 1.03
Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention. CNS Neurol Disord Drug Targets (2010) 1.02
Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J Virol (2004) 1.00
Distinct roles of lymphotoxin alpha and the type I tumor necrosis factor (TNF) receptor in the establishment of follicular dendritic cells from non-bone marrow-derived cells. J Exp Med (1997) 0.99
The role of complement in the acquired immune response. Immunology (2000) 0.98
Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J Exp Med (1998) 0.96
Complement and its role in protection and pathogenesis of flavivirus infections. Vaccine (2008) 0.96
Comparative functional evolution of human and mouse CR1 and CR2. J Immunol (2008) 0.95
Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun (2014) 0.94
Complement and humoral immunity. Vaccine (2008) 0.94
DNA epitope vaccine containing complement component C3d enhances anti-amyloid-beta antibody production and polarizes the immune response towards a Th2 phenotype. J Neuroimmunol (2008) 0.94
App1: an antiphagocytic protein that binds to complement receptors 3 and 2. J Immunol (2009) 0.93
Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes. Clin Exp Immunol (2000) 0.93
B cell acquisition of antigen in vivo. Curr Opin Immunol (2009) 0.92
Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice. Vaccine (2011) 0.91
Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci U S A (2011) 0.90
Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol (2009) 0.90
Complement receptors and the shaping of the natural antibody repertoire. Springer Semin Immunopathol (2004) 0.90
Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J Virol (2006) 0.90
Transcriptional effects of a lupus-associated polymorphism in the 5' untranslated region (UTR) of human complement receptor 2 (CR2/CD21). Mol Immunol (2012) 0.89
Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cells. J Exp Med (2010) 0.88
The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo. J Exp Med (2003) 0.88
Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1. J Immunol (2013) 0.87
Complement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytes. PLoS One (2012) 0.87
Enhancement of lectin pathway haemolysis by immunoglobulins. Clin Exp Immunol (1999) 0.86
Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier. Infect Immun (2005) 0.85
Allograft rejection: effect of local synthesis of complement. Springer Semin Immunopathol (2005) 0.85
T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice. Virology (2006) 0.84
Uncoupling CD21 and CD19 of the B-cell coreceptor. Proc Natl Acad Sci U S A (2009) 0.82
Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization. DNA Cell Biol (2008) 0.82
Bar Mitzvah for B-1 cells: how will they grow up? J Exp Med (1997) 0.82
Complement-dependent transport of antigen into B cell follicles. J Immunol (2010) 0.82
How Follicular Dendritic Cells Shape the B-Cell Antigenome. Front Immunol (2016) 0.81
Interleukin 4 gene-defective mice reconstituted with wild-type bone marrow fail to produce normal immunoglobulin E levels. J Exp Med (1998) 0.81
Synergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell response. PLoS Pathog (2013) 0.81
Searching for genes involved in the pathogenesis of primary immunodeficiency diseases: lessons from mouse knockouts. J Clin Immunol (1997) 0.81
Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE). Mol Immunol (2012) 0.81
Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression. Immunobiology (2011) 0.80
B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells. Blood (2006) 0.79
T cell hybridomas to study MHC-II restricted B-cell receptor-mediated antigen presentation by human B cells. J Immunol Methods (2011) 0.79
CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. J Immunol (2010) 0.78
Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology. Hum Gene Ther (2010) 0.78
CD21 signaling via C3 regulates Purkinje cell protein 4 expression. Mol Immunol (2009) 0.78
Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21). Mol Immunol (2009) 0.78
Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3. Mol Immunol (2007) 0.77
Reduced CD19 expression and decreased memory B cell numbers in transient hypogammaglobulinemia of infancy. Clin Exp Med (2012) 0.77
An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation. J Immunol (2010) 0.76
Carotid calcification in mice: a new model to study the effects of arterial stiffness on the brain. J Am Heart Assoc (2013) 0.76
Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection. Vaccine (2008) 0.76
Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1. Immunobiology (2013) 0.75
Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice. Mol Immunol (2009) 0.75
Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2. Clin Vaccine Immunol (2008) 0.75
Co-operation between human CR1 (CD35) and CR2 (CD21) in internalization of their C3b and iC3b ligands by murine-transfected fibroblasts. Immunology (1999) 0.75
Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection. PLoS Pathog (2017) 0.75
PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism. J Immunol (2017) 0.75
CD5+ B lymphocytes in systemic lupus erythematosus patients: relation to disease activity. Clin Rheumatol (2017) 0.75
sIgM-FcμR Interactions Regulate Early B Cell Activation and Plasma Cell Development after Influenza Virus Infection. J Immunol (2017) 0.75
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin. J Immunol Methods (1977) 8.43
The structural basis of the multiple forms of human complement component C4. Cell (1984) 6.68
Atom transfer radical polymerization. Chem Rev (2001) 6.31
The role of clonal selection and somatic mutation in autoimmunity. Nature (1987) 4.66
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33
Interaction of the N-ethylmaleimide-sensitive factor with AMPA receptors. Neuron (1998) 3.90
Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. Genes Dev (2000) 3.85
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
A massive binary black-hole system in OJ 287 and a test of general relativity. Nature (2008) 3.50
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J Neurosci (2000) 3.44
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature (1984) 3.27
Geminivirus strain demarcation and nomenclature. Arch Virol (2008) 3.21
Retracted Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet (2005) 3.13
Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J (2002) 3.09
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet (2001) 2.77
Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A (1985) 2.76
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J (1996) 2.68
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia (2006) 2.66
Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol (1998) 2.52
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol (1994) 2.52
Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Sexuality in a natural population of bacteria--Bacillus subtilis challenges the clonal paradigm. Mol Ecol (1992) 2.45
Case study of the effects of atmospheric aerosols and regional haze on agriculture: an opportunity to enhance crop yields in China through emission controls? Proc Natl Acad Sci U S A (1999) 2.44
Introns are cis effectors of the nonsense-codon-mediated reduction in nuclear mRNA abundance. Mol Cell Biol (1994) 2.42
RNA profiling of cell-free saliva using microarray technology. J Dent Res (2004) 2.40
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Automatic segmentation of high-throughput RNAi fluorescent cellular images. IEEE Trans Inf Technol Biomed (2008) 2.25
Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J Biol Chem (2000) 2.18
Ginsenoside-Rd improves outcome of acute ischaemic stroke - a randomized, double-blind, placebo-controlled, multicenter trial. Eur J Neurol (2012) 2.18
Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell (1995) 2.15
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J (1985) 2.09
Mammalian nonsense codons can be cis effectors of nuclear mRNA half-life. Mol Cell Biol (1994) 2.09
In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09
In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol (2005) 2.07
Retracted CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice. Clin Exp Immunol (2009) 2.06
Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia (2007) 2.04
Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J (1987) 2.00
Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat. J Virol (1994) 1.98
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol (2000) 1.95
Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun (2000) 1.94
A flexible light-directed DNA chip synthesis gated by deprotection using solution photogenerated acids. Nucleic Acids Res (2001) 1.92
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med (1996) 1.83
Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79
Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int (2007) 1.79
Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst (1998) 1.78
Structure and organization of the C4 genes. Philos Trans R Soc Lond B Biol Sci (1984) 1.78
Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) (2006) 1.77
Karyotypic Variation within Clonal Lineages of the Rice Blast Fungus, Magnaporthe grisea. Appl Environ Microbiol (1993) 1.75
Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73
Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall. Circ Res (1995) 1.73
BSF binds specifically to the bicoid mRNA 3' untranslated region and contributes to stabilization of bicoid mRNA. Mol Cell Biol (2001) 1.70
Affinity analysis of idiotype-positive and idiotype-negative Ars-binding hybridoma proteins and Ars-immune sera. Mol Immunol (1983) 1.67
Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A (1999) 1.66
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
MinK-KvLQT1 fusion proteins, evidence for multiple stoichiometries of the assembled IsK channel. J Biol Chem (1998) 1.64
An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol Cell Biol (1996) 1.64
Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol (2000) 1.63
The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med (1996) 1.61
The cytoskeleton of digestive epithelia in health and disease. Am J Physiol (1999) 1.61
The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice. Blood (1995) 1.61
Cytotoxic T lymphocyte sequential killing of immobilized allogeneic tumor target cells measured by time-lapse microcinematography. J Immunol (1978) 1.60
Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59
Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial. Ann Rheum Dis (2008) 1.59
Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J Virol (2010) 1.58
Concurrence of sarcoidosis and aortitis: case report and review of the literature. Ann Rheum Dis (2000) 1.57
Cloning of a human complement component C4 gene. Proc Natl Acad Sci U S A (1983) 1.56
A macrophage invasion mechanism of pathogenic mycobacteria. Science (1997) 1.55
MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene (2012) 1.55
A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest (1997) 1.53
Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem (1994) 1.53
Fluctuations of CD4+ T-cell subsets in remitting-relapsing multiple sclerosis. Ann Neurol (1988) 1.53